Velsipity Launch Webinar

17 th October 2024
18:00-19:15

Velsipity is indicated for the treatment of patients 16 years of age
and older with moderately to severely active ulcerative colitis (UC)
who have had an inadequate response, lost response, or were
intolerant to either conventional therapy, or a biological agent.

AGENDA

17 th October 2024

Time
Topic
Speaker
18:00-18:05
Welcome and introductions
18:05-18:25
Lifting the burden of UC
Charlie Lees
18:25-18:45
An introduction to VELSIPITY (etrasimod) – Peter Irving
Peter Irving
18:45-19:00
Clinical experience exchange
Peter Irving & Charlie Lees
19:00-19:15
Q&A and close
Time
Topic
12:45 - 13:00
Joining and Registration
13:00 - 13:30
Old Moulds - New Problems: Managing Fungal Infections in the ICU - Dr Stone
13:30 - 13:50
Cresemba ICU case study - Ms Nwankwo
13:50 - 14:00
Q&A
14:00
Close